Pharmmental Group — partner for launching in Russia/EAEU Contract manufacturing Manufacturing, registration and distribution

We help marketing authorization holders bring their products to the markets of Russia and the EAEU. We handle tech transfer, dossier adaptation, registration, GMP manufacturing, quality control, serialization, and market access through public procurement.

Please send information about your drug so we can discuss a potential partnership

  • Tech transfer
  • CTD/eCTD registration
  • GMP manufacturing
  • Distribution & tenders

Partnership models

Ideal partner profile

For IP holders looking for a partner with manufacturing and commercialization capabilities in Russia and the EAEU.

  • Contract manufacturing

    Full-cycle contract manufacturing — from technology transfer to GMP-compliant finished product release, including packaging, labeling, and quality control

  • License

    A partnership model where we localize and register the product under license, managing the entire manufacturing process and regulatory compliance

  • Exclusivity / co-exclusivity

    We assume full responsibility for the product’s market launch, promotion, and development, ensuring registration, marketing, and distribution across Russia and the EAEU

Pharmaceutical manufacturing
2manufacturing sites in Moscow

Advantages

Our advantages

We ensure a full cycle of pharmaceutical product launch and promotion — from technology transfer to commercial supply

  • Full cycle

    From agreement to distribution — we handle technology transfer, registration, GMP manufacturing, and logistics, ensuring quality control at every stage

  • Manufacturing facilities

    Aseptic manufacturing of solutions and lyophilized products, as well as production of solid dosage forms, aerosols, and APIs

  • Extensive distribution network

    Proprietary warehousing and logistics infrastructure, including cold chain capabilities, with nationwide coverage and expertise in government tenders

How we work

Technology transfer and registration

We handle technology adaptation, registration dossier preparation (CTD/eCTD), and conduct of local clinical trials if required. We also manage responses to regulatory queries, lifecycle management (variations), and pharmacovigilance

  1. Step 1

    Technology adaptation

    From agreement to distribution — we handle technology transfer, registration, GMP manufacturing, and logistics, ensuring quality control at every stage

  2. Step 2

    Preparation of CTD/eCTD dossiers

    We develop or adapt registration dossiers in compliance with the requirements of the Russian Ministry of Health and the EAEU, including the CMC section, quality reports, and safety data

  3. Step 3

    Clinical trials

    If required, we conduct preclinical studies and clinical trials (bioequivalence, pharmacokinetics, efficacy, and safety)

  4. Step 4

    Interaction with regulatory authorities

    We support the expert evaluation process, prepare responses to regulatory queries, implement necessary adjustments, and liaise with the authorities until the Marketing Authorization is granted

  5. Step 5

    Pharmacovigilance outsourcing

    Upon market launch, we ensure safety monitoring, dossier variation management, labeling updates, and pharmacovigilance reporting

Project form

Submit a project

Share your product details and partnership terms — we will contact you to discuss the market launch potential

We reply within 3 business days

Or contact us directly

+7 (499) 685-00-15 phm@phm.group
01Contact details

02Product and registration

03Launch and commercialization

Requirements

* — required fields

Thank you!

Your project has been successfully submitted. We will contact you within 3 business days to discuss the details of our cooperation.